Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Timothy Shaver (NPI 1336145804)

Field	Value
Entity Type	Individual
Organization	Timothy Shaver
Address	1921 N Webb Rd
City	Wichita
State	KS
ZIP	67206
Taxonomy	Rheumatology Physician
NPI Enumerated	June 21, 2005

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

This provider’s commercial data footprint in our dataset is effectively single‑payer: lifetime Medicare revenue is $3M while Medicaid shows none (no Medicaid billing on file), so all observable billed activity in this profile is Medicare‑driven and assessment of Medicaid exposure or dual‑payer dynamics is not possible from these records. The absence of Medicaid claims limits visibility into the provider’s participation in state safety‑net contracts or Medicaid formularies.

Revenue concentration is high around physician‑administered biologics: the precomputed top three Medicare codes account for 51.9% of total Medicare revenue, driven by J0129 ($687.7K revenue (22.7% of this provider's total Medicare revenue)), J9312 ($469.4K revenue (15.5% of this provider's total Medicare revenue)), and J3262 ($416.3K revenue (13.7% of this provider's total Medicare revenue)). This means a majority of Medicare dollars flow through a small set of high‑cost injectable drugs rather than routine E/M visits or lab work.

The code mix is characteristic of a rheumatology practice that provides high volumes of physician‑administered biologic therapies: top line J‑codes include J0129 (abatacept), J9312 (rituximab), J3262 (tocilizumab), J0717 (certolizumab pegol), and J1745 (infliximab). These are therapies typically given under direct supervision in an infusion or injection setting, and their prominence suggests the practice operates significant infusion throughput as a core service line rather than primarily office‑based management alone.

Competitive standing for the leading biologic agents is mixed but notable: J9312 ranks #21 of 317 providers nationally (94th percentile; typical, unremarkable volume for this code), J0129 ranks #132 of 1221 providers (89th percentile; typical, unremarkable volume for this code), and J3262 ranks #87 of 618 providers (86th percentile; typical, unremarkable volume for this code). Additionally, J0897 (denosumab) is identified as 96th percentile and labeled notably above typical national volume for this code, indicating above‑average activity on that specific agent relative to peers.

Infusion and administration activity is unusually concentrated relative to many peers: administration/infusion codes such as 96365 (581 claims, $27.3K revenue) rank in the 97th percentile and are described as notably above typical national volume, 96372 (856 claims, $9.4K revenue) ranks in the 99th percentile and is described as an extreme outlier, and add‑on infusion code 96415 ranks in the 97th percentile (350 claims, $7.4K revenue). Together these high percentiles for infusion codes corroborate a high‑throughput infusion operation and suggest operational emphasis on drug administration capacity.

Office E/M and routine testing represent a small share of revenue despite some high national ranks: 99213 contributes $52.7K (1.7% of Medicare revenue) and is labeled an extreme outlier, far above typical national volume (rank #8378 of 457151, 98th percentile), while common labs (80053, 85025, 36415) produce modest revenue shares. This pattern—low absolute revenue from E/M but high relative rank—suggests the provider bills many brief office encounters or has high per‑provider visit counts while the bulk of practice economics are driven by biologic drug reimbursement.

Tenure data indicate an established presence in Medicare billing: the NPI was enumerated on 2005-06-21 (~21 years ago), which supports the likelihood of an experienced specialty practice with sustained infusion and biologic therapy workloads. Longevity combined with high percentiles on multiple drug and administration codes suggests operational scale rather than a transient spike in activity.

For payers and network managers, the profile flags concentrated exposure to high‑cost, physician‑administered immunomodulators and notable infusion throughput, which has implications for contracting, site‑of‑care reimbursement strategy, and drug acquisition negotiations. Given the concentration (51.9% from the top three codes) and the absence of Medicaid billing, payers should evaluate reimbursement arrangements and utilization management specifically around the listed J‑codes and infusion services when assessing cost and access implications for Medicare beneficiaries served by this provider.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

44 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	20,230	$30	$687.6K
J9312	Injection, rituximab, 10 mg	7,450	$60	$469.4K
J3262	Injection, tocilizumab, 1 mg	83,260	$10	$416.3K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	81,600	$1	$326.4K
J0897	Injection, denosumab, 1 mg	16,740	$20	$301.3K
J3111	Injection, romosozumab-aqqg, 1 mg	33,390	$10	$267.1K
J1602	Injection, golimumab, 1 mg, for intravenous use	19,440	$10	$194.4K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	7,220	$20	$173.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	890	$60	$52.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	340	$90	$29.1K

Showing 1–10 of 44

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 44 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Timothy Shaver — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

44 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	1	20	8,000	$30	$291.5K
J3262	1	10	60,820	$1	$243K
J0717	2	10	51,600	$1	$200.4K
J3111	2	10	17,700	$10	$198.5K
J9312	1	10	2,500	$60	$194.7K
J1602	5	20	14,360	$10	$167.7K
J1745	2	20	3,110	$30	$96.9K
J0897	7	180	2,160	$20	$81.5K
82306	25	160	40	$30	$27.1K
96413	27	80	80	$90	$26.3K

Showing 1–10 of 44

Related Providers

Other providers that share a Tax Identification Number (TIN) with Timothy Shaver, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Shadi Shahouri	KS	Rheumatology Physician	$1.9M	$0
Melanie Rohr	KS	Rheumatology Physician	$1.2M	$0
Maya Estephan	KS	Internal Medicine Physician	$849.5K	$0
Rawaa Ebrahem	KS	Rheumatology Physician	$757.4K	$0
Stacy Wagner	KS	Medical Physician Assistant	$57.8K	$0
Kathleen Dang-pham	KS	Physician Assistant	$43.4K	$0
Jamie Agan	KS	Physician Assistant	$34.8K	$0
Praveena Gorantla	KS	Rheumatology Physician	$31.8K	$0

Nearby Providers

Other providers in the same ZIP code as Timothy Shaver, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Childrens Dentistry Of Wichita	KS	Pediatric Dentistry	$0	$32.8M
Trust Homecare, LLC	KS	Home Health Agency	$0	$28.4M
Good Shepherd Hospice Wichita LLC	KS	Community Based Hospice Care Agency	$0	$17.7M
Grene Vision Group LLC	KS	Ophthalmology Physician	$0	$6.3M
Anthem Wichita Management, LLC	KS	Alzheimer Center (Dementia Center)	$0	$4.3M
Justin Gooden	KS	Undersea and Hyperbaric Medicine (Preventive Medicine) Physician	$4.3M	$0
Jonas Lichty	KS	Oral and Maxillofacial Surgery (Dentist)	$2.6K	$2.9M
Homestead Of Crestview Operations LLC	KS	Assisted Living Facility	$0	$2.8M
Kansas Kids Heart Center, PA	KS	Pediatric Cardiology Physician	$0	$2.7M
Remy Blanchaert	KS	Oral and Maxillofacial Surgery (Dentist)	$4.1K	$2.4M

Timothy Shaver — Billing Profile & Reimbursement Data

Sign up for Timothy Shaver — Billing Profile & Reimbursement Data policy alerts

Timothy Shaver — Billing Profile & Reimbursement Data

Sign up for Timothy Shaver — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References